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It has been known since the turn of the century that antigen-specific suppression of 
antibody production can be induced by the oral administration  of antigen  (1,  2).  It 
was later shown that this mode of antigen administration  also suppressed the ability 
of an animal to respond to the antigen with a  delayed-type hypersensitivity response 
(3).  Both of these phenomena have been repeatedly verified with modern techniques 
using protein  (4-7) as well as cellular (8-10) antigens. It has further been shown that 
antigen-specific  suppressor  T  cells  (Ts) 1 are  formed  after  the  feeding  of protein 
antigens  (7,  11),  contact sensitizing agents  (6), and cellular antigens  (9).  Nonimmu- 
noglobulin serum suppressor factors (10) and antigen-antibody complexes (8,  12) have 
also  been  reported  to mediate  unresponsiveness  after  antigen  feeding.  The  present 
experiments demonstrate that antigen feeding leads to the production of at least two 
distinct, antigen-specific suppressor factors. 
Our previous studies of rats fed sheep erythrocytes (RBC) (SRBC) have shown that 
both Ts and soluble T cell-derived suppressor factors (TsF) are induced (9).2 Numerous 
reports  characterizing  TsF  produced  by  mice  have  appeared  (13-23),  including 
reports  of TsF  specific  for  SRBC.  Because  immunoregulatory  circuits  and  T  cell 
subsets are more fully characterized in mice than  in rats, and because congenic mice 
make  genetic  experiments  accessible  in  mice,  in  the  present  experiments  TsF  were 
induced in mice by feeding with SRBC. 
We report  here  that  the oral  administration  of antigen  leads  to the  release  of at 
least  two  different  antigen-specific  TsF  by spleen  cells.  These  TsF  differ  from  one 
another  in the subsets  of T  cells they influence  as well  as in the  genetic  restrictions 
they demonstrate  in  inducing suppression.  Their  ability  to bind  to SRBC  has  also 
allowed us to prepare antisera specific for each factor in sheep. 
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Materials and Methods 
RBC.  SRBC  were  obtained  (Colorado  Serum  Co.,  Denver,  Colo.)  in  sterile  Alsever's 
solution.  Before  use,  they  were  washed  three  times  in  cold  RPMI-1640  (Microbiological 
Associates,  Walkersville, Md.)  and  resuspended  to  the  desired  concentration. Horse  RBC 
(HRBC) and burro RBC (BRBC) (Colorado Serum Co.) were similarly prepared. 
Mice.  C57BL/6,  BALB/c,  SJL/J,  and  DBA/2  mice  were  obtained from  The Jackson 
Laboratory, Bar Harbor, Maine. C57BL/10, B 10.D2, and BALB.B were bred at Yale University 
(New Haven, Conn.), and were kindly donated by Dr. D.  B. Murphy. C.AL20, BAB-14, and 
CB.20 were from our own colony at Yale University. All mice used were 6-10 wk old. 
Feeding of SRBC.  C57BL/6 mice were ether anesthetized and given 0.3 ml of a 50% SRBC 
suspension via stomach tube. The feedings were carried out daily for at least 5 d, and the mice 
were killed 18-24 h after the last feeding. In some experiments, BALB/c and B10.D2 were also 
treated in this manner. 
Generation of Factors.  Spleen cells from the SRBC-fed mice (and unfed mice as controls) were 
washed three times in cold RPMI-1640 and were cultured in the same medium in a 5% CO2 
atmosphere at a concentration of 2 ×  107 cells/ml in 50-ml vessels (flask 3023; Falcon Labware, 
Div. of Becton, Dickinson & Co., Oxnard, Calif.). In every 50 ml of culture, 0.1  ml of 10% 
SRBC was added. After 48 h, the suspension was centrifuged at 5,000 g for 20 min, and the 
supernate was concentrated  10-20 times with an Amicon diafihration unit (Amicon Corp., 
Scientific Sys. Div., Lexington, Mass.) using a PM-10 filter. 5 ml of this concentrate was placed 
on a 2.5 X  100-cm Sephadex G-100,column (Pharmacia Fine Chemicals, Div. of Pharmaeia, 
Inc., Piseataway, N. J.), which was flowing at a constant rate of 0.2 ml/min with phosphate- 
buffered saline, pH 7.2, as the column buffer. The void volume that contained the immuno- 
globulins was discarded, and two distinct peaks were eluted from the column. One peak had a 
60-75 ×  10  a mol wt (fraction I [FrI]), and the other peak had a 30-40 ×  l0  s mol wt (fraction 
II [FrII]). Each fraction was concentrated to 2 ml, dialyzed against RPMI-1640 for 24 h at 5°C, 
and stored at -70°C in 0.2-ml aliquots after filtration with a 0.22-/~m Millipore filter (Millipore 
Corp., Bedford, Mass.). Molecular weights were estimated by using a series of molecular weight 
standards to calibrate the Sephadex G-100 column: aldolase (158,000 tool wt); bovine serum 
albumin (BSA) (68,000 mol wt); ovalbumin (45,000 mol wt); and chymotrypsinogen A (25,000 
mol wt). 
Absorption of Factors.  0.5 ml of packed SRBC or HRBC was incubated with  1 ml of FrI or 
FrII for 45  min in a  37°C water bath. The cells were removed by centrifugation, and the 
resultant supernates were then tested for activity along with a sample from the same batch that 
had undergone the same incubation treatment without the RBC. 
Preparation of Anti-Factor Antisera.  Samples of blood were collected from two sheep (2318 and 
2537) in sterile bottles that contained citrate at the Yale animal facilities. 2 ml of packed freshly 
drawn cells from sheep 2318 were incubated with 2 ml of FrI at 37°C for 45 min, and the same 
was done with the cells of sheep 2537 and FrII. After this adsorption step, the cells were washed 
once and brought up to 3 ml with phosphate-buffered saline and each was mixed with 3 ml of 
complete .Freund's adjuvant. The thick paste  that  resulted after vigorous mixing was  then 
injected back into the sheep from which the SRBC were drawn. Intramuscular injections of 1.5 
ml in each of four sites were given to each sheep.  1 mo later, the procedure was repeated with 
complete adjuvant. 4 wk after the second injection, the sheep were bled out, and the sera were 
tested against each of the factors by Ouchteriony gel diffusion and were then stored at -20°C. 
Cell Separation.  In some experiments, purified T and B cells were prepared according to the 
method of Wysocki and Sato (24). Briefly, plastic Petri dishes  (8-757-12, Fisher Scientific Co., 
Fair Lawn, N. J.)  were precoated with goat anti-mouse immunoglobulin,  and 3 ml (2 ×  107 
cells) of spleen cells was incubated on these plates for 70 min at 4°C. The nonadherent cells 
were removed and were used as a purified T cell population. After additional washes and a 45- 
min incubation at 37°C, the adherent cells were removed and used as a population of purified 
B cells. Staining with appropriate antisera showed only a slight (1-3%) cross-contamination. 
In some eases, the purified T cells were further treated with anti-Lyt-2.2 serum (a gift of Dr. 
Fung-Win Shen, Memorial Sloan-Kettering Cancer Center, New York)  plus complement. For 
this treatment, 2 ×  l0  T  T  cells were suspended in 2.5 ml of a  1:25 dilution of anti-Lyt-2.2 sera 
and incubated for 30 min at 37°C. After washing, the cells were resuspended in 2.5 ml of a  1: J.  A.  MATTINGLY, J.  M.  KAPLAN,  AND C.  A. JANEWAY,  JR.  547 
10 dilution of rabbit complement for 30 min at 37°C. The cells were then washed three times, 
and  staining revealed that  ~30%  of the  treated cells were  viable, with only  1-2%  showing 
positive fluorescence with anti-Lyt-2.2 sera (25). 
Cell Culture.  1 ml of a spleen cell suspension that contained 10  7 cells was placed in each well 
of  a  tissue  culture  plate  (3008;  Falcon  Labware,  Div.  of  Becton,  Dickinson  &  Co.).  A 
modification of the Mishell and  Dutton culture system  (26)  was used, because the medium 
consisted of RPMI-1640 plus 10% fetal calf serum (Grand Island Biological Co., Grand Island, 
N. Y.), supplemented with 2 mM L-glutamine (Grand Island Biological Co.), 5 ×  10 -5 M  2- 
mercaptoethanol (Matheson, Coleman, & Bell, East Rutherford, N. J.), gentamicin (Schering 
Corp., Kenilworth, N. J.), and Hepes buffer (Sigma Chemical Co., St. Louis, Mo.) to pH 7.3. 
All cultures contained 0.025 ml of 1% SRBC, HRBC, or BRBC  (~2 X  l0  s RBC), and some 
also received 0.2 ml of a soluble factor preparation. Control cultures received either 0.2 ml of 
a control factor preparation, or were simply adjusted to volume with 0.2 ml RPMI-1640. These 
cultures were  incubated  for  either  3  or 5  d  at  37°C  in  a  5%  CO2  atmosphere  with  100% 
humidity. The  use of this modified medium eliminated the need for daily culture nutritive 
additives. 
Triplicate  cultures  were  assayed  for  direct  plaque-forming  cells  (PFC)  (27)  using  the 
Cunningham  and Szenberg modification (28).  Results are reported as mean  PFC/culture + 
SEM. 
Results 
Generation of Specific, Nonimmunoglobulin Suppressor Factors.  .The supernate  from  cul- 
tures of spleen cells from SRBC-fed mice was always suppressive when assayed in an 
in  vitro anti-SRBC  Mishell-Dutton  culture.  Because  antibody  is known  to  be sup- 
pressive of this response, the supernate was fractionated on Sephadex G-100. The void 
volume was discarded; two peaks of approximate molecular weight 60,000-75,000  (Fr 
I)  and  30,000-40,000  (FrII) were obtained. Table I  demonstrates  that  each of these 
peaks  contained  active  suppressive  material,  and  that  suppression  was  specific  for 
SRBC,  because  the  addition of the  factor  to  in  vitro cultures  in  which  HRBC  or 
BRBC were antigens did not suppress. Suppression titered out for both FrI and FrII 
at >1:10. All subsequent experiments use FrI and FrII at  1:6-1:10. 
Both Factors Bind Specifically to the Antigen.  Because of the specificity for SRBC  of 
both of the factors, we next tested for binding of the factors to specific antigen. Both 
FrI and  FrII bind to SRBC  but  do not  bind to HRBC  or BRBC  (Table II). Thus, 
antigen specificity of function reflects a  specific antigen binding site on each factor. 
Time-Course of Suppression.  We next examined the time-course of the effect of each 
factor during primary in vitro responses to SRBC  (Table III). Both  factors suppress 
the response when PFC are measured at day 5 of culture. However, FrII added at the 
initiation of the culture led to marked increases in the number of SRBC  PFC found 
on day 3 of culture, after which responses in the presence of FrII steadily declined to 
suppressed levels by day 5 of culture. FrI was suppressive at all times in all experiments. 
Genetic Restrictions in the Effects of Suppressor Factors.  Because interactions of T  cells 
or T  cell-derived factors with other cells are frequently restricted by genetic differences 
at various loci, we next examined the ability of our suppressor factors to interact with 
spleen cells derived from various strains of mice. In particular, we determined the role 
of major  histocompatibility complex  (MHC)  genes,  immunoglobulin  heavy-chain 
gene complex (Igh) genes, and genes in the B10 background on these factors. 
As seen in Table IV, studies with three different sets of FrI derived from  different 
strains of mice  show  no  effect of MHC-  or Igh-linked genes on  the activity of this 
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TAnLE  I 
Both FrI and FrII Specifically Suppress Day-5 SRBC-PFC Formation by B6 
Spleen Cells In  Vitro 
Factor  Final dilution  Antigen  Day-5 PFC 
None  --  SRBC  5,460 +  380 
FrI  1:5  SRBC  633 ±  166 
Frl  1:10  SRBC  800 ±  100 
Frl  1:25  SRBC  3,660 +  233 
FrI  1:50  SRBC  5,100 ±  650 
FrI  l : 100  SRBC  5,220 +  480 
FrlI  1:5  SRBC  820 ±  180 
FrII  1  : 10  SRBC  640 ±  60 
FrII  1:25  SRBC  2,880 :t: 333 
FrII  1:50  SRBC  5,866 ±  666 
FrII  1:100  SRBC  5,900 +  300 
None  --  HRBC  2,120 ±  166 
FrI  1:10  HRBC  1,880  zt: 210 
FrII  1:10  HRBC  2,280 -  133 
None  --  BRBC  1,620  ±  180 
FrI  1:10  BRBC  1,680  ±  100 
FrII  1:10  BRBC  1,500  +  133 
B6 spleen cells were cultured with antigen ±  factor and PFC determined on 
the immunizing RBC after 5 d; values represent mean ±  1 SE. 
TABLE  II 
Both Frl and FrH Bind Specifically to SRBC 
Cells  Factor  Adsorption*  SRBC 
PFC/culture 
B6 spleen  None  --  6,430 +  533 
B6 spleen  Frl  --  1~420 +  180 
B6 spleen  FrI  SRBC  6,000 +  440 
B6 spleen  FrI  HRBC  1~840 +  233 
B6 spleen  FrI  BRBC  2,480 +  200 
B6 spleen  FrlI  --  2~660 -1- 266 
B~5 spleen  FrlI  SRBC  5,140 +  340 
B6 spleen  FrII  HRBC  3,140 +  140 
B6 spleen  FrII  BRBC  2,980 +  100 
Underlined  values are  suppressed.  Factors  were  added  to  cultures  of B6 
spleen cells plus SRBC and PFC determined on day 5 of culture. 
* Incubated with  RBC  for 45 rain  at  37°C.  See Materials and Methods for 
details.  : 
(including  B10.A[2R])  (data  not  shown),  even  though  B10.D2  and  B10.A(2R)  (not 
shown)  produce  active  FrI.  This  is reminiscent  of a  TsF  described  by Taniguchi  et al. 
(29),  which  would  also  not  suppress  any  B10  strain.  This  restriction  is  also  strong J.  A.  MATTINGLY, J.  M.  KAPLAN,  AND  C.  A. JANEWAY, JR. 
TABLE  III 
Kinetics of Activity of Frl and Frll: Induction of Early Help and Feedback 
Suppression by Frll 
Cells  Factor*  Day 3  Day 4  Day 5 
PFC/culture 
B6 spleen  None  0  60 +  100  1,640 ±  220 
B6 spleen  FrI  0  50 ±  50  170 +  133 
B6 spleen  FrII  4,900 ±  666  900:1:133  330 ±  160 
* Factors were added at day 0 of culture. 
549 
TABLE  IV 
Genetic Restriction of Action of Frl TsF on Spleen Cell Anti-SRBC Responses 
Responding 
strain 
Background  H-2  Ig-H 
Percent suppression using Frl from 
C57BL/6  B 10.D2  BALB/c 
C57BL/6  C57BL/6  b  b  a6 
B10  b  b  [] 
BALB/c  BALB  d  a  -- 
C.B20  BALB  d  b  -- 
C.AL20  BALB  d  e  -- 
DBA/2  DBA/2  d  c  84 




-18  ] 
88  70 
100  100 
100  100 
Percent  suppression --  (1  -  response in presence of TsF/response in absence of TsF)  X  100. Absence of 
suppression and matching disparities are boxed. 
TABLE  V 
Genetic Restriction of Action of Frll TsF on Spleen Cell Anti-SRBC Responses 
Responding  Background  H-2  Ig-H 
strain 
Percent suppression using FrlI from 
C57BL/6  B 10.D2  BALB/c 
% 
C57BL/6  C57BL/6  b  b  71  --  -- 
BI0  B10  b  b  85  --  -- 
BI0.D2  B10  d  []  89  68 
BALB/c  BALB  d  [~]  --  ~-]  84 
BALB.B  BALB  b  --  74 
C.B20  BALB  d  []  --  100  [] 
C.AL20  BALB  d  []  --  I  13  27] 
DBA/2  DBA/2  d  []  ~  --  -- 
SJL/J  SJL  s  b  82  --  -- 
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TABLE  VI 
Effect of TsF on B Cells, B Cells Plus Ly-I  T Cells, and Spleen Cells 
Day-5 PFC response to SRBC with* 
Responding  Experiment 1  Experiment 2 
population 
Control  Frl  FrII  Control  Frl  Frll 
B cells:~  140 +  80  620 ±  120  300 ±  66  70 +  66  90 ±  40  180 ±  133 
B cells plus  5,420 ±  433  5,800 ±  300  9,880 +  520  540 +  120  500 ±  80  2,200 ±  233 
Ly-1 T 
cells§ 
Whole spleen  ND  ND  ND  3,840 ±  300  940 ±  100  1,960 ±  266 
* TsF produced by C57BL/6J mice fed SRBC. 
:]: Produced by anti-mouse Ig plate separation (24) of spleen cells from C57BL/6J. ND, not done. 
§ B cells plus Ly-1 T cells prepared by lysis of plate-purified T cells with anti-Ly-2.2 and complement. 
TABLE  VII 
Cells Receiving the Factors  * 
Pretreated  Factors 
cells~ 
PFC/cuhure on day 5 on precultured cells 
added to 
B cells  B cells +  T cells 
None  40 +  66  3,100 +  300 
T cells  --  1,720 +  333  1,720 +- 266 
T cells  FrI  480 +  120  0 
T cells  FrlI  500 -I- 66  300 +  120 
Ly-1 T cells  --  2,620 +  366  3,380 +  500 
Ly-I T cells  FrI  2,950 +  400  3,040 +  40 
Ly-1 T cells  FrII  5,100 +  220  1,240 +  133 
* Frl is accepted by Ly-2 ÷ T cells to induce suppression, whereas FrII is accepted by 
Ly-2  T  cells (to induce enhancement in the absence of Ly-2 + cells and to induce 
feedback suppression in the presence of Ly-2 ÷ cells). 
~: C57BL/6-pretreated T cells were cultured for 96 h with SRBC and the correspond- 
ing factors,  harvested, washed, and added to a new 5-d culture of responding cells. 
Each cell population listed numbered 5 ×  106 cells, and no additional factors were 
added to these cultures after transfer of pretreated cells. 
evidence against  trivial explanations  for the activity of FrI, such as that  it is antigen 
or anti-SRBC  antibody. 
The  results obtained  with  FrII  (Table  V)  reveal  a  different  pattern  of restriction. 
Here,  MHC-linked  genes and  genes in the B10 background  do not  restrict  the effect 
of FrII on the day 5  PFC  response. However, in all cases in which the Igh genes of the 
responding  cells differ from  those of the FrII  producer  strain, no suppression  is seen. 
Studies  with  allotype  congenics such  as  the C.B20,  which  is a  BALB/c  mouse  with 
Igh  genes derived  from  C57BL,  clearly  map  this restriction to  the Igh-linked  genes. 
Again,  this  finding  negates  trivial  explanations  of  the  activity  of  this  factor.  The 
finding of Igh-linked restriction in a  factor that appears  to induce a  feedback-type of 
suppression  is  reminiscent  of the  recent  finding of a  similar  restriction  in  feedback 
suppression by Eardley et al.  (30). 
Analysis of the Mode of Action  of Suppressor Factors.  At present, three facts point  to T 
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and  the  fact  that  spleen  cells  treated  with  anti-Thy-l.2  and  complement  do  not 
produce suppressor factors (negative data not shown). However, the T  cell nature of 
the producing cells has not been proven with purified T  cells. 
On the other hand, the cells activated by each suppressor factor have been partially 
characterized. First, the factors were added to cultures of B cells alone, or cultures of 
B cells plus Ly- 1 T  cells (or whole spleen). As seen in Table VI, neither factor affected 
(helped) either day-3 (not shown) or day-5 responses of B cells. When added to B cells 
plus Ly-1 T  cells, Fr! did not suppress, but FrII led to increased responses on day 3 
and day 5 of culture. Because both factors suppress the day-5 response of whole spleen, 
this suggested that  FrI was a  suppressor inducer factor similar to that described by 
Tada (31), which required an Ly-2  + cell (Ly-123 or Ly-23) for its action, whereas FrII 
induced heightened activity in a cell set that had both helper and inducer of feedback 
suppression activities, similar to the Ly-1, Qa-1 + T cell set defined by the experiments 
of Cantor et al. (32) and McDougal et al. (33). 
To  further explore  this  possibility,  purified  T  cells  or  purified  Ly-1  cells  were 
euhured for 4  d  with SRBC and either FrI or FrII. The cells were then recovered, 
thoroughly washed, and added to either B cells or B cells plus T  cells from normal 
mice. The results are given in Table VII.  FrI  has no effect when  precultured with 
anti-Ly-2-treated cells,  whether these are  added  to  B  cells or B  cells plus  T  cells. 
However, when it is cultured with unfractionated T cells, it induces potent suppression 
in these cells for both responses. In contrast, FrII has very pronounced effects on anti- 
Ly-2-treated cells.  When Ly-1 cells precuhured with FrII and SRBC are added to B 
cells, a marked increase in helper activity at day 5 is seen. However, when these same 
cells are added to B plus T  cell cultures, potent suppression is observed. Thus, FrII 
would appear to activate inducers of feedback suppression that are also Ly-1 helper 
T  cells. 
Discussion 
These experiments demonstrate that the oral administration of antigen can induce, 
some days later,  the  production of at  least  two suppressive factors by spleen cells. 
These factors are both antigen specific and nonimmunoglobulin in nature, and their 
production is sensitive to anti-Thy-l.2 and complement. Thus, it is highly likely that 
they  are  produced  by T  cells.  However, this  needs  to  be  confirmed ~  by  positive- 
selection experiments now in progress. 
It is our goal in these experiments to relate the activity of these factors to the known 
immunoregulatory circuits defined in several experimental systems. Thus, FrI most 
closely resembles the TsF ofTada et al. (1O, 20, 31), in that it will not work on strains 
with  the B10  background,  and  does not  affect Ly-1  helper cells directly. It  rather 
serves to activate suppression  from Ly-2  + T  cells  (Ly-123 or Ly-23 ~ells,  or both). 
Preliminary data suggest that  FrI is bound by anti-I-J antibody. However, it is not 
apparently MHC restricted in its activity. In this, it more closely resembles a series of 
TsF isolated by Benacerraf and his colleagues (14-lfi), which are antigen specific, I-J 
positive, and  induce suppression  in T  cell populations  that  have not  been further 
defined by anti-Ly fractionation. Perhaps these two sets of factors form different parts 
of the same suppressor-amplification loop, involving signals  delivered by an  Ly-23 
cell to an Ly-123 cell, leading to increased Ly-23 suppressor activity. 
FrII appears to be a novel suppressor factor. It apparently acts by inducing a subset 552  ANTIGEN-SPECIFIC SUPPRESSOR FACTORS 
of Ly- 1 T  cells that has both potent helper activity and the ability to induce feedback 
suppression. Thus, FrII would appear to activate the Ly-1, Qa-I + subset  defined as 
containing both a  helper T  cell and the inducers of feedback suppression by Cantor 
et  al.  (32).  We believe both activities  (help  and  induction  of feedback suppression) 
derive from a single cell. This hypothesis is now being tested with these factors. The 
finding that the activity of FrII was restricted only by Igh-linked genes is also similar 
to  the  finding  of  such  a  restriction  in  the  activity  of  the  inducers  of  feedback 
suppression described by Eardley et al.  (30).  Preliminary studies suggest  FrII is I-A 
positive and I-J negative. 
Besides further studies aimed at defining the producing and accepting cells for these 
factors, their chemical nature is also being investigated. Thus far, we have su~zceeded 
in producing sheep anti-factor antisera, each of which will precipitate novel proteins 
from the surface of radio-iodinated mouse T  cells (R. E. Cone, R. W. Rosenstein, and 
C.  A. Janeway.  Unpublished  data.).  Anti-FrI  will  also  give a  line  in  Ouchterlony 
diffusion with purified anti-trinitrophenyl TsF prepared by the method of Zembala 
and  Asherson  (23).  These  antisera  should  allow  the  purification  of these  activities 
from a  variety of different  culture  supernates.  Finally,  our studies  will  attempt  to 
demonstrate that the incubation of these inducing TsF with their target populations 
gives rise to a set of effector TsF currently being analyzed by K. Yamauchi and R. K. 
Gershon (Manuscript in preparation.) at Yale University. 
Summary 
The feeding of sheep erythrocytes (SRBC)  to mice leads to the production of two 
distinct T  cell-derived suppressor factors by spleen cells.  Each has been characterized 
for specificity, genetic restrictions, and cellular interactions. 
Fraction I has a 60,000-75,000  mol wt, is specific for antigen, and is suppressive of 
primary  in  vitro  anti-SRBC  responses  at  all  times.  It  is  not  restricted  by  major 
histocompatibility complex (MHC)- or Igh-linked genes, but it fails to suppress spleen 
cells derived from any strain of mouse with a  B10 background.  It acts on an Lyt-2  + 
T  cell to increase suppressive activity. An antiserum has been prepared against  this 
factor that reacts with other, unrelated T  cell suppressor factors. 
Fraction  II has an ~30,000-40,000  mol wt, is specific for antigen,  and has a  dual 
effect on in vitro anti-SRBC responses. On day 3 of culture, it leads to augmentation 
of the  response, whereas  at  day 5  it  suppresses  the  response.  It  is  not  restricted  by 
MHC genes, but  it is restricted by Igh-linked genes. It acts by activating an Ly-1 T 
cell to both help and induce feedback suppression. 
These factors, and the antisera prepared against them, should allow more precise 
dissection of the molecular pathways by which immunoregulatory cells communicate 
with one another. 
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